D.E. Shaw & Co’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $442K | Buy |
82,396
+63,639
| +339% | +$341K | ﹤0.01% | 2564 |
|
|
2025
Q1 | $100K | Buy |
18,757
+7,382
| +65% | +$39.4K | ﹤0.01% | 2843 |
|
|
2024
Q4 | $102K | Buy |
11,375
+1,207
| +12% | +$10.8K | ﹤0.01% | 2804 |
|
|
2024
Q3 | $112K | Sell |
10,168
-14
| -0.1% | -$154 | ﹤0.01% | 2880 |
|
|
2024
Q2 | $92.7K | Buy |
+10,182
| New | +$92.7K | ﹤0.01% | 2908 |
|
|
2022
Q2 | – | Sell |
-24,809
| Closed | -$166K | – | 4139 |
|
|
2022
Q1 | $166K | Sell |
24,809
-13,398
| -35% | -$89.6K | ﹤0.01% | 3668 |
|
|
2021
Q4 | $206K | Sell |
38,207
-7,863
| -17% | -$42.4K | ﹤0.01% | 3476 |
|
|
2021
Q3 | $407K | Buy |
+46,070
| New | +$407K | ﹤0.01% | 2929 |
|
|
2016
Q3 | – | Sell |
-232
| Closed | -$52K | – | 2482 |
|
|
2016
Q2 | $52K | Hold |
232
| – | – | ﹤0.01% | 2475 |
|
|
2016
Q1 | $70K | Sell |
232
-205
| -47% | -$61.9K | ﹤0.01% | 2505 |
|
|
2015
Q4 | $208K | Sell |
437
-91
| -17% | -$43.3K | ﹤0.01% | 2415 |
|
|
2015
Q3 | $256K | Buy |
+528
| New | +$256K | ﹤0.01% | 2276 |
|